Re: Sex-based subgroup differences in randomized controlled trials: empirical evidence from Cochrane meta-analyses.
Alison Avenell(University of Aberdeen), Edwin van Teijlingen(Bournemouth University), Fiona Stewart, Pat Hoddinott(University of Stirling), Christopher T. Robertson(University of Arizona), B. Boachie, Daryll Archibald, Fiona Douglas(University of Southern California)
Open Access Institutional Repository at Robert Gordon University (Robert Gordon University)
November 24, 2016
Cited by 0
Related Papers
Gene Mutations in the Succinate Dehydrogenase Subunit SDHB Cause Susceptibility to Familial Pheochromocytoma and to Familial Paraganglioma
|The American Journal of Human Genetics|2001|1.1k
Cancer Risks for BRCA1 and BRCA2 Mutation Carriers: Results From Prospective Analysis of EMBRACE
|JNCI Journal of the National Cancer Institute|2013|946
Germline <i>BRCA</i> Mutations Are Associated With Higher Risk of Nodal Involvement, Distant Metastasis, and Poor Survival Outcomes in Prostate Cancer
|Journal of Clinical Oncology|2013|833
Germline mutations in RAD51D confer susceptibility to ovarian cancer
|Nature Genetics|2011|545
Maximising the impact of qualitative research in feasibility studies for randomised controlled trials: guidance for researchers
|Pilot and Feasibility Studies|2015|482